FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

AI and machine learning can transform fragmented and unstructured healthcare data. But how do you refine it into useful, ...

In a statement sent to Nextgov/FCW, an FDA spokesperson said that Makary’s posture on AI integration is to enhance human expertise without replacing it. “When used responsibly, AI can enhance ...

The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement genAI across the agency by 30 June ...

with full integration on June 30, following the completion of a new generative AI pilot for scientific reviewers. Once the FDA receives an application for the potential approval of a drug ...